- Home
- STRO vs MIN Comparison
STRO vs MIN Comparison
Compare STRO & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- MIN
- Stock Information
- Founded
- STRO 2003
- MIN 1988
- Country
- STRO United States
- MIN United States
- Employees
- STRO N/A
- MIN N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- MIN Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- MIN Finance
- Exchange
- STRO Nasdaq
- MIN Nasdaq
- Market Cap
- STRO 292.6M
- MIN 313.0M
- IPO Year
- STRO 2018
- MIN N/A
- Fundamental
- Price
- STRO $2.89
- MIN $2.66
- Analyst Decision
- STRO Strong Buy
- MIN
- Analyst Count
- STRO 7
- MIN 0
- Target Price
- STRO $12.14
- MIN N/A
- AVG Volume (30 Days)
- STRO 596.9K
- MIN 331.0K
- Earning Date
- STRO 11-13-2024
- MIN 01-01-0001
- Dividend Yield
- STRO N/A
- MIN 7.31%
- EPS Growth
- STRO N/A
- MIN N/A
- EPS
- STRO N/A
- MIN 0.08
- Revenue
- STRO $160,955,000.00
- MIN N/A
- Revenue This Year
- STRO N/A
- MIN N/A
- Revenue Next Year
- STRO N/A
- MIN N/A
- P/E Ratio
- STRO N/A
- MIN $33.38
- Revenue Growth
- STRO 230.90
- MIN N/A
- 52 Week Low
- STRO $2.13
- MIN $2.52
- 52 Week High
- STRO $6.13
- MIN $2.88
- Technical
- Relative Strength Index (RSI)
- STRO 32.85
- MIN 33.18
- Support Level
- STRO $4.01
- MIN $2.69
- Resistance Level
- STRO $4.60
- MIN $2.75
- Average True Range (ATR)
- STRO 0.36
- MIN 0.04
- MACD
- STRO -0.06
- MIN -0.01
- Stochastic Oscillator
- STRO 3.93
- MIN 2.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.